Connection

Julian Schulze Zur Wiesch to Aged

Back to Details
This is a "connection" page, showing publications Julian Schulze Zur Wiesch has written about Aged.
Julian Schulze Zur Wiesch
Connection Strength
0.168
Aged
  1. Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza. Sci Rep. 2021 03 11; 11(1):5803.
    View in: PubMed
    Score: 0.017
  2. B cell analysis in SARS-CoV-2 versus malaria: Increased frequencies of plasmablasts and atypical memory B cells in COVID-19. J Leukoc Biol. 2021 01; 109(1):77-90.
    View in: PubMed
    Score: 0.016
  3. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease. Front Immunol. 2020; 11:1870.
    View in: PubMed
    Score: 0.016
  4. Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73- Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes. Cells. 2020 07 22; 9(8).
    View in: PubMed
    Score: 0.016
  5. Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients. Medicine (Baltimore). 2019 Aug; 98(32):e16721.
    View in: PubMed
    Score: 0.015
  6. Detection of a Broad Range of Low-Level Major Histocompatibility Complex Class II-Restricted, Hepatitis Delta Virus (HDV)-Specific T-Cell Responses Regardless of Clinical Status. J Infect Dis. 2019 01 29; 219(4):568-577.
    View in: PubMed
    Score: 0.014
  7. CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation. J Acquir Immune Defic Syndr. 2018 04 01; 77(4):345-349.
    View in: PubMed
    Score: 0.014
  8. Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03). J Med Virol. 2018 02; 90(2):304-312.
    View in: PubMed
    Score: 0.013
  9. Assessment of the HIV-1 reservoir in CD4+ regulatory T cells by a Droplet Digital PCR based approach. Virus Res. 2017 08 15; 240:107-111.
    View in: PubMed
    Score: 0.013
  10. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression. J Leukoc Biol. 2017 05; 101(5):1263-1271.
    View in: PubMed
    Score: 0.013
  11. Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients. J Clin Virol. 2020 09; 130:104549.
    View in: PubMed
    Score: 0.004
  12. Control of SARS-CoV-2 infection in rituximab-treated neuroimmunological patients. J Neurol. 2021 Jan; 268(1):5-7.
    View in: PubMed
    Score: 0.004
  13. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018; 9:2611.
    View in: PubMed
    Score: 0.004
  14. Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center. Infection. 2018 Dec; 46(6):847-853.
    View in: PubMed
    Score: 0.003
  15. Autoantibodies against "rods and rings"-related IMPDH2 in hepatitis C genotype 1 and DAA therapy in a "real life" cohort. Med Microbiol Immunol. 2017 Oct; 206(5):379-382.
    View in: PubMed
    Score: 0.003
  16. Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01). Clin Infect Dis. 2016 11 15; 63(10):1320-1324.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.